Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score ‑matched analysis

This study aimed to investigate the association of sodium-glucose cotransporter 2 inhibitors (SGLT2i) use with cardiovascular (CV) clinical outcomes in type 2 diabetes (T2D) patients with acute coronary syndro...

Source: Cardiovascular Diabetology - March 25, 2024 Category: Cardiology Authors: Tao Liu, Zeyuan Fan, Bing Xiao, Chang He and Shicong Wang Tags: Research Source Type: research